Published on 20 Mar 2024 on Investing.com
Precigen shares hold with $14 target on pivotal trial focus
Precigen shares hold with $14 target on pivotal trial focus
NASDAQ.PGEN price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free